Comparative Effectiveness of Semaglutide and Tirzepatide for Weight Loss in Adults with Overweight and Obesity in the US: A Real-World Evidence Study

Patricia J Rodriguez, Brianna M Goodwin Cartwright, Samuel Gratzl, Rajdeep Brar, Charlotte Baker, Ty J. Gluckman, Nicholas L Stucky
doi: https://doi.org/10.1101/2023.11.21.23298775

Article Information

doi 
https://doi.org/10.1101/2023.11.21.23298775
History 
  • November 22, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Patricia J Rodriguez, PhD, MPH1,
  2. Brianna M Goodwin Cartwright, MS1,
  3. Samuel Gratzl, PhD1,
  4. Rajdeep Brar, MD1,
  5. Charlotte Baker, DrPH, MPH, CPH1,
  6. Ty J. Gluckman, MD, MHA2 and
  7. Nicholas L Stucky, MD, PhD1,†
  1. 1Truveta, Inc, Bellevue, WA
  2. 2Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Providence St Joseph Health, Portland, OR
  1. ↵†Corresponding author:
    Dr Nicholas Stucky, Truveta, Inc, 1745 114th Ave SE, Bellevue, WA 98004, Email: nicholass{at}truveta.com
Back to top
Posted November 22, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Comparative Effectiveness of Semaglutide and Tirzepatide for Weight Loss in Adults with Overweight and Obesity in the US: A Real-World Evidence Study
Patricia J Rodriguez, Brianna M Goodwin Cartwright, Samuel Gratzl, Rajdeep Brar, Charlotte Baker, Ty J. Gluckman, Nicholas L Stucky
medRxiv 2023.11.21.23298775; doi: https://doi.org/10.1101/2023.11.21.23298775
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area